Considerable Differences in Burden of Disease at State Level

Share this content:
Considerable Differences in Burden of Disease at State Level
Considerable Differences in Burden of Disease at State Level

TUESDAY, April 10, 2018 (HealthDay News) -- There are considerable differences in the burden of disease at the state level, according to a study published in the April 10 issue of the Journal of the American Medical Association.

Ali H. Mokdad, Ph.D., from the University of Washington in Seattle, and colleagues from the U.S. Burden of Disease Collaborators describe trends in the burden of diseases, injuries, and risk factors at the state level from 1990 to 2016 using the results of the Global Burden of Disease Study.

The researchers observed a decrease in the overall death rates between 1990 and 2016 in the United States, from 745.2 to 578.0 per 100,000 persons. From 1990 to 2016, among adults aged 20 to 55 years, there was a decrease in the probability of death in 31 states and Washington, D.C. The highest and lowest life expectancies at birth were seen for Hawaii (81.3 years) and Mississippi (74.7 years) in 2016. For 1990 and 2016, the leading causes of disability-adjusted life years (DALYs) were ischemic heart disease and lung cancer; the third leading cause was low back pain and chronic obstructive pulmonary disease in 1990 and 2016, respectively. From 1990 to 2016, opioid use disorders moved up from the 11th to the seventh leading cause of DALYs.

"These data can be used to inform national health priorities for research, clinical care, and policy," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve ...

Diagnostic error is the most common cause of medical errors that patients report

HbA1c Variability Is a Strong Predictor of Mortality in T2DM

HbA1c Variability Is a Strong Predictor of Mortality ...

HbA1c variability is a powerful, independent measure, regardless of how it is measured

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Actual probability of death for patients on liver transplant wait list underestimated by up to 17%

is free, fast, and customized just for you!




Already a member?

Sign In Now »